Adial Pharmaceuticals Prices $3.6 Million Public Offering of Common Stock and Warrants

Blank Rome has advised Adial Pharmaceuticals. Sullivan & Worcester has advised A.G.P./Alliance Global Partners.Adial Pharmaceuticals, a clinical-stage biopharmaceutical company listed on NASDAQ, has announced the pricing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here